- Pharmaceutical companies
- Asia
- Singapore
- Novartis
Novartis in Singapore
Addresses:
-
Novartis (Singapore) Pte Ltd., 20 Pasir Panjang Road, #10-25/28 Mapletree Business City, Singapore Country 117439, Singapore
Phone: 6567226010
Fax: 6562211726
-
Novartis (Singapore) Pte Ltd., 20 Pasir Panjang Road, #10-25/28 Mapletree Business City, Singapore Country 117439, Singapore
Phone: 6567226010
Fax: 6563234335
-
Novartis Asia Pacific Pharmaceuticals Pte Ltd, 20 Pasir Panjang Road, #10-25/28 Mapletree Business City, Singapore Country 117439, Singapore
Phone: 6567226010
Fax: 6563234335
-
Novartis Asia Pacific Pharmaceuticals Pte Ltd, Sandoz Asia Pacific Regional Office, 20 Pasir Panjang Road, #10-25/28 Mapletree Business City, Singapore Country 117439, Singapore
Phone: 6567226010
Fax: 6568380818
-
Novartis Institute for Tropical Diseases Pte Ltd, Ernst & Young Solutions LLP, 1 Raffles Quay #18-01, Singapore Country 048583, Singapore
Phone: 6567222900
Fax: 6567222910
-
Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, 10 Tuas Bay Lane, Singapore Country 637461, Singapore
Fax: 6563047150
-
Novartis Singapore Pharmaceutical Manufacturing Pte Ltd., 8 Tuas Bay Lane, Singapore Country 636986, Singapore
Fax: 6566976464
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Belgium
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsEi vielä rekrytointiaMultippeliskleroosi, uusiutuva-remitoiva
-
Novartis PharmaceuticalsEi vielä rekrytointiaNivelreuma | Systeeminen lupus erythematosus | Sjögrensin tauti
-
Novartis PharmaceuticalsEi vielä rekrytointiaKohonnut Lp(a) ja todettu ateroskleroottinen sydän- ja verisuonisairaus
-
Novartis PharmaceuticalsRekrytointiMultippeliskleroosin uusiutuvat muodotEspanja
-
Novartis PharmaceuticalsRekrytointi
-
Novartis PharmaceuticalsEi vielä rekrytointia
-
Novartis PharmaceuticalsRekrytointiMultippeliskleroosi (MS)Ranska
-
Novartis PharmaceuticalsEi vielä rekrytointia
-
Novartis PharmaceuticalsRekrytointiHR+HER2 – pitkälle edennyt rintasyöpäVenäjän federaatio
-
Novartis PharmaceuticalsRekrytointiSepelvaltimotauti | Määrittämättömän potentiaalin klooninen hematopoiesis (CHIP)Saksa, Kanada
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.